1033810-70-6 Usage
General Description
"[1,2,4]Triazolo[1,5-a]pyridin-7-ol" is a chemical compound with potential use in medicinal chemistry due its structural uniqueness. It is recognized by its distinctive heterocyclic ring system, which includes a triazole and a pyridine ring fused together. The characteristics of this structure, particularly its conjugated system and nitrogen atoms, significantly contribute to its biological activity. It's frequently used moiety in drug discovery due its properties of enhancing solubility, hydrogen-bonding capabilities, and metabolic stability.
Check Digit Verification of cas no
The CAS Registry Mumber 1033810-70-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,3,8,1 and 0 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1033810-70:
(9*1)+(8*0)+(7*3)+(6*3)+(5*8)+(4*1)+(3*0)+(2*7)+(1*0)=106
106 % 10 = 6
So 1033810-70-6 is a valid CAS Registry Number.
1033810-70-6Relevant articles and documents
PYRROLO[2,1-F][1,2,4]TRIAZINE DERIVATIVES SERVING AS SELECTIVE HER2 INHIBITORS AND APPLICATION THEREOF
-
, (2021/03/18)
The present invention relates to a group of pyrrolo[2, 1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and an application thereof in the preparation of a drug that serves as an HER2 inhibitor. Specifically, the present invention relates to a compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof.
Processes and intermediates for the preparation of N4-phenyl-quinazoline-4-amine derivatives
-
Page/Page column 66, (2009/09/05)
This invention provides compounds of Formula (I), wherein B, G, A, E, R1, R2, R3, m and n are as defined herein, which are useful as type I receptor tyrosine kinase inhibitors, and methods of use thereof in the treatment of hyperproliferative disorders in mammals.